| Cash Flow | 2025-09-28 | 2025-06-29 | 2025-03-30 | 2024-09-29 |
|---|---|---|---|---|
| Revenue-Core Illumina | 3,184 | 2,100 | 1,041 | - |
| Cost of revenue-Core Illumina | 1,073 | 722 | 358 | - |
| Research and development-Core Illumina | 728 | 499 | 252 | - |
| Selling and marketing-Core Illumina | 458 | 311 | 165 | - |
| General and administrative-Core Illumina | 319 | 190 | 102 | - |
| Goodwill and intangible impairment-Core Illumina | 0 | 0 | - | - |
| Legal contingency and settlement-Core Illumina | 0 | - | - | - |
| Revenue-GRAILInc. | 0 | 0 | 0 | - |
| Total operating expense-GRAILInc. | 0 | 0 | 0 | - |
| Consolidated other (expense) income, net-GRAILInc. | -103 | -110 | -18 | - |
| Consolidated provision for income taxes-GRAILInc. | 193 | 122 | 51 | - |
| Net income (loss) | 516 | 366 | 131 | -1,410 |
| Depreciation expense | 153 | 103 | 52 | 170 |
| Amortization of intangible assets | 51 | 34 | 17 | 113 |
| Share-based compensation expense | 212 | 142 | 73 | 291 |
| Deferred income taxes | -82 | -41 | -16 | 161 |
| Net (gains) losses on strategic investments | 137 | 133 | 32 | -342 |
| Change in fair value of contingent consideration liabilities | -29 | -32 | -11 | -304 |
| Goodwill and intangible (ipr&d) impairment | - | - | - | 1,889 |
| Goodwill and intangible impairment | 23 | 23 | - | - |
| Property and equipment and right-of-use asset impairment | 4 | 0 | 0 | 32 |
| Gain on helix contingent value right | 0 | 0 | 0 | 15 |
| Other | -18 | -9 | 2 | -11 |
| Accounts receivable | -13 | -49 | -46 | -20 |
| Inventory | 43 | 28 | -10 | 9 |
| Prepaid expenses and other current assets | 1 | -11 | -6 | 11 |
| Operating lease right-of-use assets and liabilities, net | 25 | 17 | 8 | 21 |
| Other assets | 13 | 3 | 1 | 14 |
| Accounts payable | -13 | -26 | -15 | -35 |
| Accrued liabilities | -69 | -91 | -56 | -406 |
| Other long-term liabilities | 16 | 26 | 14 | -9 |
| Net cash provided by operating activities | 758 | 474 | 240 | 473 |
| Net purchases of property and equipment | 93 | 62 | 32 | 99 |
| Net purchases of strategic investments | 63 | 43 | 24 | 33 |
| Cash paid for acquisitions and intangible assets, net of cash required | 7 | 7 | 7 | 81 |
| Cash received for helix contingent value right | 0 | - | - | 83 |
| Net cash used in investing activities | -163 | -112 | -63 | -130 |
| Common stock repurchases | 700 | 570 | 200 | 99 |
| Taxes paid related to net share settlement of equity awards | 24 | 23 | 22 | 2 |
| Proceeds from issuance of common stock | 44 | 28 | 27 | 56 |
| Payments on contingent consideration liabilities | 1 | 1 | - | 1 |
| Proceeds from debt, net of issuance costs | 0 | - | - | 1,241 |
| Payments on debt obligations | 0 | - | - | 750 |
| Grail cash deconsolidated as a result of spin-off | 0 | 0 | - | 968 |
| Borrowings on delayed draw term loan, net of issuance costs | - | 0 | - | - |
| Net cash used in financing activities | -681 | -566 | -195 | -523 |
| Effect of exchange rate changes on cash and cash equivalents | 9 | 11 | 4 | 1 |
| Net decrease in cash and cash equivalents | -77 | -193 | -14 | -179 |
| Cash and cash equivalents at beginning of period | 1,127 | 1,127 | 1,127 | 1,048 |
| Cash and cash equivalents at end of period | 1,050 | 934 | 1,113 | 869 |
ILLUMINA, INC. (ILMN)
ILLUMINA, INC. (ILMN)